Subchronic Toxicity Of Ethanolic Extract of Cassytha filiformis L. on The Renal Function of Rat
Article Sidebar
Main Article Content
Abstract
Sub-chronic toxicity test of the deffated ethanolic extract of tali putri (Cassytha filiformis L.) on the rat renal function has been carried out. A number of 16 male rats aged 2-3 months, weighing ±250 g were used as experimental animals. The rats were divided into 4 groups which consisted of 1 control group and 3 extract-treated groups given 1.25, 2.5, and 5 mg/kg extract administrated intraperitoneally once a day for 14 days. The creatinine clearance, renal function, and the ratio of renal were calculated and analyzed by two-way ANOVA followed by Duncan’s test. The study showed that the creatinine clearance and renal function decreased significantly during treatment (p<0.05). The kidney weight ratio of groups treated with extract, especially with greater doses, showed a very significant increase as compared with control (p<0,01). These indicated that the ethanolic extract of C. filiformis on the doses of 1.25 – 5 mg/kg might decrease the renal function, althought it seemed to be relatively safe when used for 14 days.
Article Details
The authors retain the copyright and grant the journal the right of first publication simultaneously under the Creative Commons Attribution License. This license allows others to share the work with proper acknowledgment of authorship and initial publication in this journal. Authors are permitted and encouraged to deposit their articles in institutional repositories, on their personal websites, or in other online repositories after the article has been published in JSFK.
References
Barnes, P. M., Powell-Griner, E., McFann, K., & Nahin, R. L. (2004). Complementary and alternative medicine use among adults: United States, 2002. Adv Data. 2004;343:1-19.
World Health Organization (WHO). Desember 2008. Traditional medicine diakses 16 April 2014 dari https://www.who.int/mediacentre/factsheet/fs134/en/.
Supardi, S., Jamal, S., & Raharni, R. (2005). Pola Penggunaan Obat, Obat Tradisional dan Cara Tradisional dalam Pengobatan Sendiri di Indonesia. Buletin Penelitian Kesehatan, 33(4),192-198.
Quetin-Leclercq, J., Hoet, S., Block, S., Wautier, M. C., & Stevigny, C. (2004). Studies on Cassytha filiformis from Benin: isolation, biological activities and quantification of aporphines. Proceedings of bioresources towards drug discovery and development. pp, 81-107.
Hoet, S., Stévigny, C., Block, S., Opperdoes, F., Colson, P., Baldeyrou, B., ... & Quetin-Leclercq, J. (2004). Alkaloids from Cassytha filiformis and related aporphines: antitrypanosomal activity, cytotoxicity, and interaction with DNA and topoisomerases. Planta Medica, 70(5), 407-413.
Kumar, V., Gogoi, B., Meghvansi, M., Singh, L., Srivastava, R. & Deka, D. (2009) Determining the antioxidant activity of certain medicinal plants of Sonitpur, (Assam), India using DPPH assay. Journal of Phytology, 1(1), 49-56.
Armenia. 2007. Efek Ekstrak Butanol Tali putri Sebagai Antikoagulan Pada Mencit Putih Jantan. Padang: Universitas Andalas. (Unpublished).
Tsai, T. H., Wang, G. J., & Lin, L. C. (2008). Vasorelaxing alkaloids and flavonoids from Cassytha filiformis. Journal of Natural Products, 71(2), 289-291.
Permana, Y. A. 2011. Pengaruh Ekstrak Etanol Herba Tali Putri (Cassytha filiformis L.) Terhadap Kadar Glukosa Darah Mencit Diabetes. Skripsi. Padang: Fakultas Farmasi Universitas Andalas.
Sahu, R. K., Roy, A., Maurya, A. K., & Kumar, R. (2012). Screening of Antipyretic and Analgesic Potential of Ethanol Extract of Cassytha filiformis Leaves. Research Journal of Science and Technology, 4(3), 129-131.
Yuliandra, Y., Armenia, & Arifin H. (2013, October). Studi Efek Antihipertensi Tumbuhan Tali Putri (Cassytha filiformis L.) Pada Tikus Hipertensi yang Diinduksi Prednison dan Garam. Prosiding Seminar Nasional Perkembangan Terkini Sains Farmasi dan Klinik III.
Armenia, Yuliandra Y., & Sattar M. Z. A. (2014). Comparative effectiveness of defatted hypotensive crude extract, ethyl acetate and butanolic fractions of Cassytha filiformis L. on different models of hypertensive rats. World Journal of Pharmacy and Pharmaceutical Sciences, 3(12), 200-208.
Ernst, E. (1998). Harmless herbs? A review of the recent literature. The American Journal of Medicine, 104(2), 170-178.
Sari, L. O. R. K. (2006). Pemanfaatan obat tradisional dengan pertimbangan manfaat dan keamanannya. Majalah Ilmu Kefarmasian, 3(1), 01-07.
Winarno, M., Widowati, L., & Sundari, D. (2015). Studi Keamanan Ramuan Jamu untuk Hiperurisemia dan Hipertensi. Buletin Penelitian Kesehatan, 43(3), 137-146.
Bent, S. (2008). Herbal medicine in the United States: review of efficacy, safety, and regulation. Journal of General Internal Medicine, 23(6), 854-859.
Bagnis, C. I., Deray, G., Baumelou, A., Le Quintrec, M., & Vanherweghem, J. L. (2004). Herbs and the kidney. American Journal of Kidney Diseases, 44(1), 1-11.
Sohn, S. H., Lee, H., Nam, J. Y., Kim, S. H., Jung, H. J., Kim, Y., ... & Bae, H. (2009). Screening of herbal medicines for the recovery of cisplatin-induced nephrotoxicity. Environmental Toxicology and Pharmacology, 28(2), 206-212.
Vanherweghem, J. L. (1998). Misuse of herbal remedies: the case of an outbreak of terminal renal failure in Belgium (Chinese herbs nephropathy). The Journal of Alternative and Complementary Medicine, 4(1), 9-13.
Nortier, J. L., Martinez, M. C. M., Schmeiser, H. H., Arlt, V. M., Bieler, C. A., Petein, M., ... & Vanherweghem, J. L. (2000). Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi). New England Journal of Medicine, 342(23), 1686-1692.
WHO Traditional Medicine Strategy 2014-2023. (2013). Geneva, World Health Organization.
Babayi, H. M., Joseph, J. I., Abalaka, J. A., Okogun, J. I., Salawu, O. A., Akumka, D. D., ... & Inyang, U. S. (2007). Effect of oral administration of aqueous whole extract of Cassytha filiformis on haematograms and plasma biochemical parameters in rats. Journal of Medical Toxicology, 3(4), 146-151.
Mythili, S., Sathiavelu, A., & Sridharan, T. B. (2011). Evaluation of antioxidant activity of Cassytha filiformis. International Journal of Applied Biology and Pharmaceutical Technology, 2(2), 380-385.
Depkes RI. (2005). Kriteria dan Tata Laksana Pendaftaran Obat Tradisional, Obat Herbal Terstandar, dan Fitofarmaka. Jakarta: Depkes RI.
Sherwood, L. (2015). Human physiology: from cells to systems. Cengage learning.
Lu, F. C. (1985). Basic toxicology. Fundamentals, target organs, and risk assessment. Hemisphere Publishing, New York, NY(USA).
Chandrasoma, P. & Taylor, C. R. (1995). Cell Degenartion & Necrosis in Concise Pathology. 3rd Ed. McGraw-Hill.
Kaplan, A. & Szabo, L. L. (1979). The Kidney of Test Renal Function. Clinical chemistry: Interpretation and techniques. Philadelphia: Lea and Febiger.
Shargel, L., Wu-Pong, S., & Andrew B. C. Yu. (2004). Applied Biopharmaceutics & Pharmacokinetics. McGraw-Hill's.
Van Lente, F., & Suit, P. (1989). Assessment of renal function by serum creatinine and creatinine clearance: glomerular filtration rate estimated by four procedures. Clinical Chemistry, 35(12), 2326-2330.
Flores, J., DiBona, D. R., Beck, C. H., & Leaf, A. (1972). The role of cell swelling in ischemic renal damage and the protective effect of hypertonic solute. Journal of Clinical Investigation, 51(1), 118.
Maxwell, P. (2003). HIF-1: an oxygen response system with special relevance to the kidney. Journal of the American Society of Nephrology, 14(11), 2712-2722